Bioassays for the characterisation and control of therapeutic cytokines; determination of potency.

R Thorpe, M Wadhwa, C Page, A Mire-Sluis
{"title":"Bioassays for the characterisation and control of therapeutic cytokines; determination of potency.","authors":"R Thorpe,&nbsp;M Wadhwa,&nbsp;C Page,&nbsp;A Mire-Sluis","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The primary value of bioassays is that they alone directly assess the biological activity of bioactive substances and products like cytokines. Appropriately designed bioassays reflect the fundamental aspects of the biological activity of a cytokine molecule, including ligand-receptor binding, signal transduction processes (often poorly understood) and the final observed biological effects. Biological assays therefore complement physicochemical and biochemical procedures which normally only assess precise molecular structural features of cytokines. Bioassays provide valuable information concerning the potency of cytokine products. This is essential for evaluating batch-to-batch consistency, appropriate formulations and stability. Bioassay data are crucial at all stages in the development of cytokine products, from early research to final quality control of finished product. However, the type and design of bioassays may differ according to the information required and its intended use. The assays may or may not directly relate to the clinical use of the product. Bioassays can be difficult to perform and time consuming, although this often reflects bad assay choice and/or design. Correct analysis of the assay results is essential if valid data are to be obtained. Standardisation, using correctly calibrated primary and secondary standards, is essential. In vivo bioassays are normally more unreliable than in vitro procedures, but in some cases in vitro systems are either not available or do not address important biological characteristics of a product. Bioassays must be validated for their intended purpose and for the types of samples to be measured. Appropriate statistical analysis should be used to derive the significance and specifications of results. This needs to address both variability in samples and assay performance. Specifications (limits) for product acceptability need to be derived from real data using several batches of cytokine product.</p>","PeriodicalId":11308,"journal":{"name":"Developments in biological standardization","volume":"97 ","pages":"61-71"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developments in biological standardization","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The primary value of bioassays is that they alone directly assess the biological activity of bioactive substances and products like cytokines. Appropriately designed bioassays reflect the fundamental aspects of the biological activity of a cytokine molecule, including ligand-receptor binding, signal transduction processes (often poorly understood) and the final observed biological effects. Biological assays therefore complement physicochemical and biochemical procedures which normally only assess precise molecular structural features of cytokines. Bioassays provide valuable information concerning the potency of cytokine products. This is essential for evaluating batch-to-batch consistency, appropriate formulations and stability. Bioassay data are crucial at all stages in the development of cytokine products, from early research to final quality control of finished product. However, the type and design of bioassays may differ according to the information required and its intended use. The assays may or may not directly relate to the clinical use of the product. Bioassays can be difficult to perform and time consuming, although this often reflects bad assay choice and/or design. Correct analysis of the assay results is essential if valid data are to be obtained. Standardisation, using correctly calibrated primary and secondary standards, is essential. In vivo bioassays are normally more unreliable than in vitro procedures, but in some cases in vitro systems are either not available or do not address important biological characteristics of a product. Bioassays must be validated for their intended purpose and for the types of samples to be measured. Appropriate statistical analysis should be used to derive the significance and specifications of results. This needs to address both variability in samples and assay performance. Specifications (limits) for product acceptability need to be derived from real data using several batches of cytokine product.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于表征和控制治疗性细胞因子的生物测定;效价测定。
生物测定法的主要价值在于,它们可以直接评估生物活性物质和产物(如细胞因子)的生物活性。适当设计的生物测定反映了细胞因子分子生物活性的基本方面,包括配体-受体结合、信号转导过程(通常知之甚少)和最终观察到的生物效应。因此,生物分析补充了物理化学和生物化学程序,通常只评估细胞因子的精确分子结构特征。生物测定提供了有关细胞因子产品效力的有价值的信息。这对于评估批与批之间的一致性、合适的配方和稳定性至关重要。从早期研究到成品的最终质量控制,生物测定数据在细胞因子产品开发的各个阶段都是至关重要的。然而,生物测定的类型和设计可能根据所需的信息及其预期用途而有所不同。检测结果可能与产品的临床使用直接相关,也可能不直接相关。虽然这通常反映了糟糕的测定方法选择和/或设计,但生物测定可能难以执行且耗时。如果要获得有效的数据,对测定结果进行正确的分析是必不可少的。标准化,使用正确校准的一级和二级标准,是必不可少的。体内生物测定通常比体外方法更不可靠,但在某些情况下,体外系统要么不可用,要么不能处理产品的重要生物学特性。生物测定必须根据其预期目的和要测量的样品类型进行验证。应使用适当的统计分析来得出结果的意义和规格。这需要解决样品的可变性和分析性能。产品可接受性的规格(限制)需要从使用几批细胞因子产品的真实数据中得出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Virus removal by filtration. Gamma irradiation of bovine sera. Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation. A universal virus inactivant for decontaminating blood and biopharmaceutical products. Serum and serum substitutes: virus safety by inactivation or removal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1